Europe Histopathology Services Market

Market Introduction

Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.

Europe Histopathology Services Strategic Insights

Strategic insights for the Europe Histopathology Services provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Histopathology Services Report Scope

Europe Histopathology Services Regional Insights

The geographic scope of the Europe Histopathology Services refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Europe histopathology services market is expected to reach US$ 10,327.65 million by 2028 from US$ 7,202.97 million in 2021; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028. Factors such as strategic alliances among market players and increasing prevalence of chronic diseases drive the market growth. However, limitations associated with histopathology and immunohistochemistry hinder the Europe histopathology services market growth.

Chronic diseases, such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer, are the leading causes of death and disabilities worldwide. Rapid change in lifestyle, and surge in the consumption of alcohol and tobacco products are among the prominent factors triggering the incidence of cancer among populations. Autoimmune diseases further contribute to disorders among a significant number of people. However, increasing research activities to develop effective treatments for these diseases are boosting the Europe histopathology services market growth. Researchers and therapists exploring therapies for these diseases conduct detailed histopathological analyses to understand the disease mechanisms, which assist in the designing of therapies for their management. Thus, the rising number of chronic diseases worldwide are fueling the histopathological services market growth. Further, technological developments are allowing medical professionals to upgrade their existing diagnostic procedures and protocols. Innovations in instrumentation, visualization tools, and invasion techniques are bringing improvements and greater accuracy in diseases diagnoses. Further, strategic alliances between leading and emerging market players to support the promising studies for advanced histopathological analyses are likely to serve significant future trends in the market. For instance, Telemedicine Clinic (A Unilabs Company), in partnership with Alliance Medical and Doncaster Clinical Commissioning Group (CCG), started providing reporting services for low-dose CT scans, as a part of the Targeted National Lung Health Check program of the National Health Services (NHS), UK.

Europe is facing the massive impact of an outbreak due to exponential growth of infections of COVID-19 in the region. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals. Hence, due to the lockdown in many countries, elective and cancer surgeries have reduced significantly. Moreover, due to the robust increase in the incidence of COVID- 19, pathology laboratories are now prioritizing and focusing on COVID-19 tests. The rapid increase in the number of infected patients in the UK and Germany is likely to hamper the growth of Europe histopathology services market and result in slowing down the market growth in the near future.

Key Market Segments

The Europe histopathology services market, by type of examination, is segmented into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. In 2021, the surgical specimen segment is likely to hold the largest share of the market, and it is further expected to register the highest CAGR during 2021–2028.

Based on end user, the Europe histopathology services market is segmented into diagnostic laboratories and reference laboratories, research institutes, and others. The diagnostic laboratories and reference laboratories segment is likely to hold the largest share of the market in 2021, and it is anticipated to register the highest CAGR during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Europe histopathology services market are the European Union (EU), European Society for Medical Oncology (ESMO), and Cancer Research UK.

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Europe histopathology services market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Europe histopathology services market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe histopathology services market.

EUROPE HISTOPATHOLOGY SERVICES MARKET SEGMENTATION

By Type of Examination

• Surgical Specimen
• Breast Biopsy
• Lung Biopsy
• Renal Biopsy
• Gastrointestinal Biopsy
• Pancreatic Biopsy
• Skin Tissue Biopsy
• Testicular Biopsy
• Others

By End User

• Diagnostic Laboratories & Reference Laboratories
• Research Institutes
• Others

By Country

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Company Profiles

• Acculabs Diagnostics UK Ltd
• Laboratory Corporation of America Holdings
• TPL Path Labs
• UNILABS
• Cellular Pathology Services
• Targos
• Cureline Global Translational CRO
• CHARLES RIVER LABORATORIES, INC.